Literature DB >> 8503832

Interleukin-8 is not involved in the increased chemotactic activity of peripheral blood plasma during acute myocardial infarction.

T Siminiak1, J M Schröder, M Sticherling, H Wysocki.   

Abstract

Polymorphonuclear neutrophils (PMN) are known to participate in the development of tissue injury during myocardial infarction due to both free oxygen radicals release, as well as to their involvement in the "no-reflow" phenomenon. We have previously shown that peripheral blood plasma (obtained from patients with acute myocardial infarction) has chemotactic activity for PMN and is able to induce PMN adherence as well as superoxide anion production. To investigate whether interleukin-8 (IL-8/NAP-1), a potent chemotactic factor for PMN, is involved in plasma-mediated PMN stimulation, we measured plasma levels of IL-8 in five patients with transmural myocardial infarction with highly sensitive enzyme-linked immunosorbent assay (ELISA) using specific antibodies. Blood samples were taken immediately after patients' admission, within 15 and 30 min of treatment with intravenous nitrates, as well as after 1, 2, 3, and 7 days. All samples expressed IL-8 activity within the detection limit (0.4 ng/ml) as observed at the basal state. Thus, IL-8 may not be considered as responsible for the chemotactic activity in peripheral blood in patients with myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8503832     DOI: 10.1007/BF00798263

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  30 in total

1.  Generation of NAP-1 and related peptides in psoriasis and other inflammatory skin diseases.

Authors:  J M Schröder
Journal:  Cytokines       Date:  1992

2.  Purification and partial biochemical characterization of a human monocyte-derived, neutrophil-activating peptide that lacks interleukin 1 activity.

Authors:  J M Schröder; U Mrowietz; E Morita; E Christophers
Journal:  J Immunol       Date:  1987-11-15       Impact factor: 5.422

3.  Purification and amino acid sequencing of NAF, a novel neutrophil-activating factor produced by monocytes.

Authors:  A Walz; P Peveri; H Aschauer; M Baggiolini
Journal:  Biochem Biophys Res Commun       Date:  1987-12-16       Impact factor: 3.575

4.  Detection of interleukin 8 biological activity in synovial fluids from patients with rheumatoid arthritis and production of interleukin 8 mRNA by isolated synovial cells.

Authors:  F M Brennan; C O Zachariae; D Chantry; C G Larsen; M Turner; R N Maini; K Matsushima; M Feldmann
Journal:  Eur J Immunol       Date:  1990-09       Impact factor: 5.532

5.  The chemotactic activity for granulocytes produced by virally infected fibroblasts is identical to monocyte-derived interleukin 8.

Authors:  J Van Damme; B Decock; R Conings; J P Lenaerts; G Opdenakker; A Billiau
Journal:  Eur J Immunol       Date:  1989-07       Impact factor: 5.532

6.  Purification and partial biologic characterization of a human lymphocyte-derived peptide with potent neutrophil-stimulating activity.

Authors:  J M Schröder; U Mrowietz; E Christophers
Journal:  J Immunol       Date:  1988-05-15       Impact factor: 5.422

7.  Neutrophil-activating peptide 1/interleukin 8 mRNA expression and protein secretion by human monocytes: effect of cyclosporin A.

Authors:  U Mrowietz; M Sticherling; V Mielke; J M Schröder; E Christophers
Journal:  Cytokine       Date:  1991-07       Impact factor: 3.861

8.  Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog.

Authors:  R L Engler; G W Schmid-Schönbein; R S Pavelec
Journal:  Am J Pathol       Date:  1983-04       Impact factor: 4.307

9.  Secretion of novel and homologous neutrophil-activating peptides by LPS-stimulated human endothelial cells.

Authors:  J M Schröder; E Christophers
Journal:  J Immunol       Date:  1989-01-01       Impact factor: 5.422

10.  Neutrophil-activating protein 1/interleukin 8 stimulates the binding activity of the leukocyte adhesion receptor CD11b/CD18 on human neutrophils.

Authors:  P A Detmers; S K Lo; E Olsen-Egbert; A Walz; M Baggiolini; Z A Cohn
Journal:  J Exp Med       Date:  1990-04-01       Impact factor: 14.307

View more
  3 in total

1.  Pathobiology and Clinical Impact of Reperfusion Injury.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997       Impact factor: 2.300

2.  Interleukin 8 released after acute myocardial infarction is mainly bound to erythrocytes.

Authors:  R J de Winter; A Manten; Y P de Jong; R Adams; S J van Deventer; K I Lie
Journal:  Heart       Date:  1997-12       Impact factor: 5.994

3.  Pathobiology and Clinical Impact of Reperfusion Injury.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1995       Impact factor: 2.300

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.